At Novartis, we touch the lives of millions of people worldwide

Novartis purpose is to reimagine medicine to improve and extend people's lives. We use innovative science and technology to address some of society's most challenging healthcare issues. We discover and develop breakthrough treatments and find new ways to deliver them to as many people as possible. We also aim to reward those who invest their money, time and ideas in our company.

Novartis is the second largest pharmaceutical company in the world in terms of global sales. In 2021, the company celebrated its 25th anniversary, while its predecessor companies trace their roots back to 1758. Headquartered in Basel, Switzerland, Novartis develops innovative solutions that address the evolving needs of patients and societies. Its broad range of medicines covers key therapeutic areas: hematology, oncology, cardiology, immunology, dermatology, neurology, pulmonology, and ophthalmology. Products are sold in more than 155 countries and reached more than 769 million patients in 2020.

More than 23 000 associates dedicate their work at Novartis exclusively to development. In the last five years, Novartis has been at the forefront in the pharmaceutical industry in terms of product approvals, and also obtained more than 10 approvals of breakthrough therapies from the US Food and Drug Administration (FDA).

Through various initiatives and cooperation (Novartis Access, Novartis Malaria Initiative, Novartis Healthy Family), Novartis is actively involved in increasing access to medicines and healthcare. In 2020, these programs reached 66 million patients.

The Novartis Commitment to Patients and Caregivers

The Commitment is the result of joint efforts of Novartis and over 40 patient organizations representing more than 200 million patients to further strengthen our efforts to find new ways to improve the lives of  all those who need our medicines. Find out more 

Novartis Vision

Our vision is to become the most valued and trusted medicines company in the world. More

Our Business

We are structured to deliver innovative products, exploit global scale, and respond to new opportunities and risks. Our businesses – Innovative Medicines and Sandoz – are supported by functional organizations with global scale. Research and development (R&D) is at the core of our company and central to the Novartis strategy.

Innovative Medicines

The Innovative Medicines division is made up of two business units – Novartis Pharmaceuticals, which includes Novartis gene therapies, and Novartis Oncology, which markets state-of-the-art innovative drugs in key therapeutic areas: dermatology, hematology, immunology, cardiology, neurology, ophthalmology, and oncology.

Find out more


Sandoz is a global leader in generic pharmaceuticals and biosimilars that pioneers novel approaches to help people around the world access high-quality medicines. Find out more 

Our Strategy

Novartis is a focused medicines company powered by technology leadership in research and development, word-class commercialization, global access and data science.